Leaders in Pharmaceutical Business Intelligence (LPBI) Group

Detailed Technology Description

 

For the March 2018 nomination for 2018 Yidan Foundation Prize, I was requested to provide supporting material. That effort to explain in details, by examples, what is the technology developed, expose its originality and its sustainability,  has yielded the following 70 pages document. It represents that greatest level of details applied to date in characterization of LPBI Group’s Intelectual Property by three content asset classes.

• Nomination for 2018 Yidan Prize, recognition in the field of MEDICAL education: development of curation methodologies for scientific content – 2018 Nominee, Aviva Lev-Ari, PhD, RN

https://pharmaceuticalintelligence.com/2018/10/21/nomination-for-2018-yidan-prize-recognition-in-the-field-of-medical-education-development-of-curation-methodologies-for-scientific-content-2018-nominee-aviva-lev-ari-phd-rn/

Our intellectual property “IP” consists of three classes of assets as described in detail within live links in the below, listed article.

• First, the Journal, an ongoing journal of curated, current biomedical research;
• Second, the books, a collection of 16 volumes of e-books available via Amazon in five specialties of Medicine: Cardiovascular, Genomics, Cancer, Immunology and Precision Medicine; and
• Third, real-time curation of biotech and medical conferences yielding an e-Proceedings at the end of the conference in One-click operation.

These three IP asset classes are described in details with live links in

• eScientific Publishing a Case in Point: Evolution of Platform Architecture Methodologies and of Intellectual Property Development (Content Creation by Curation) Business Model

https://pharmaceuticalintelligence.com/2019/02/04/escientific-publishing-a-case-in-point-evolution-of-platform-architecture-methodologies-and-of-intellectual-property-development-content-creation-by-curation-business-model/

It worth noting the following complementary document that explains the role that the Founder had played in the Content production process:

• Founder’s Role in the Development of Venture’s Factors of Content Production – Biographical Notes by Aviva Lev-Ari, PhD, RN, LPBI Group